Skip to Content
Merck
CN
  • Serum growth arrest-specific protein 6 levels are elevated in adult-onset Still's disease.

Serum growth arrest-specific protein 6 levels are elevated in adult-onset Still's disease.

Clinical rheumatology (2014-04-29)
Hyoun-Ah Kim, Jin-Young Nam, Ju-Yang Jung, Chang-Bum Bae, Jeong-Mi An, Ja-Young Jeon, Bong-Sik Kim, Chang-Hee Suh
ABSTRACT

We investigated the growth arrest-specific protein 6 in adult-onset Still's disease. Serums were collected from 52 adult-onset Still's disease patients with follow-up samples of 21 patients. The growth arrest-specific protein 6 levels in adult-onset Still's disease were higher compared to those in the normal controls (25.37±7.71 vs. 19.86±5.01 ng/mL, p<0.001). However, growth arrest-specific protein 6 did not correlate with disease activity. Also, growth arrest-specific protein 6 was not decreased after activity was resolved in the follow-up. The growth arrest-specific protein 6 in adult-onset Still's disease patients were higher than the normal controls. However, growth arrest-specific protein 6 was not correlated with disease activity.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-GAS6 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution